Briggs CA, Grønlien JH, Curzon P, Timmermann DB, Ween H, Thorin-Hagene K, Kerr P, Anderson DJ, Malysz J, Dyhring T, Olsen GM, Peters D, Bunnelle WH, Gopalakrishnan M.

Alkondon, Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. 1992, Pubmed

Alkondon, Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. 1992, Pubmed
Alkondon, alpha-bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. 1998, Pubmed
Anderson, [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain. 2008, Pubmed
Arredondo, Central role of alpha7 nicotinic receptor in differentiation of the stratified squamous epithelium. 2002, Pubmed
Bitner, Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways. 2007, Pubmed , Xenbase
Boess, The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents. 2007, Pubmed , Xenbase
Briggs, Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors. 2006, Pubmed , Xenbase
Briggs, Activation and inhibition of the human alpha7 nicotinic acetylcholine receptor by agonists. 1998, Pubmed , Xenbase
Briggs, Effect of MK-801 at the human alpha 7 nicotinic acetylcholine receptor. 1996, Pubmed , Xenbase
Briggs, alpha7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues. 2008, Pubmed
Briggs, Gain of function mutation of the alpha7 nicotinic receptor: distinct pharmacology of the human alpha7V274T variant. 1999, Pubmed , Xenbase
Briggs, Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands. 1995, Pubmed , Xenbase
Brüggmann, Multiple nicotinic acetylcholine receptor alpha-subunits are expressed in the arterial system of the rat. 2002, Pubmed
Buisson, Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study. 1996, Pubmed
Coggan, Evidence for ectopic neurotransmission at a neuronal synapse. 2005, Pubmed
Dickinson, Differential coupling of alpha7 and non-alpha7 nicotinic acetylcholine receptors to calcium-induced calcium release and voltage-operated calcium channels in PC12 cells. 2007, Pubmed
Dunlop, In vitro screening strategies for nicotinic receptor ligands. 2007, Pubmed , Xenbase
Edelstein, Allosteric proteins after thirty years: the binding and state functions of the neuronal alpha 7 nicotinic acetylcholine receptors. 1996, Pubmed
Egleton, Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. 2008, Pubmed
Elliott, Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits. 1996, Pubmed , Xenbase
Evans, Expression and functional characterisation of a human chimeric nicotinic receptor with alpha6beta4 properties. 2003, Pubmed , Xenbase
Fenster, Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. 1997, Pubmed , Xenbase
Fujii, Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. 2007, Pubmed
Galzi, Mutations in the channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic. 1992, Pubmed , Xenbase
Gotti, Drugs selective for nicotinic receptor subtypes: a real possibility or a dream? 2000, Pubmed
Gotti, Pharmacology and biophysical properties of alpha 7 and alpha 7-alpha 8 alpha-bungarotoxin receptor subtypes immunopurified from the chick optic lobe. 1994, Pubmed , Xenbase
Grønlien, Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes. 2007, Pubmed , Xenbase
Guo, Synaptically released and exogenous ACh activates different nicotinic receptors to enhance evoked glutamatergic transmission in the lateral geniculate nucleus. 2005, Pubmed
Hurst, A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. 2005, Pubmed , Xenbase
Jones, Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area. 2004, Pubmed
Jones, Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes. 2006, Pubmed
Kem, Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration. 2004, Pubmed , Xenbase
Li, Non-neuronal nicotinic alpha 7 receptor, a new endothelial target for revascularization. 2006, Pubmed
Lockman, Chronic nicotine exposure alters blood-brain barrier permeability and diminishes brain uptake of methyllycaconitine. 2005, Pubmed
Maggi, Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor. 1999, Pubmed , Xenbase
Olincy, Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. 2006, Pubmed
Pichat, SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. 2007, Pubmed
Salminen, Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. 2004, Pubmed
Sands, Barium permeability of neuronal nicotinic receptor alpha 7 expressed in Xenopus oocytes. 1993, Pubmed , Xenbase
Séguéla, Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. 1993, Pubmed , Xenbase
Sudweeks, Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. 2000, Pubmed
Sullivan, ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties. 1997, Pubmed , Xenbase
Tietje, Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties. 2008, Pubmed
Timmermann, An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. 2007, Pubmed , Xenbase
Trumbull, High throughput electrophysiology using a fully automated, multiplexed recording system. 2003, Pubmed , Xenbase
Turek, A sensitive technique for the detection of the alpha 7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain. 1995, Pubmed
Verbitsky, Mixed nicotinic-muscarinic properties of the alpha9 nicotinic cholinergic receptor. 2000, Pubmed , Xenbase
Wishka, Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship. 2006, Pubmed
Wonnacott, Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters. 2006, Pubmed